This Article Full Text (PDF) All Versions of this Article: 1538574408320524v1 42/4/352    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Samson, R. H. Search for Related Content PubMed PubMed Citation Articles by Samson, R. H. Social Bookmarking                         What's this?

The Role of Statin Drugs in the Management of the Peripheral Vascular Patient

From Florida State University Medical School and the Mote Vascular Foundation, Inc, Sarasota, Florida, rsamson{at}veinsandarteries.com

The impact of statin therapy on established vascular conditions and recurrent disease is most relevant for long-term care. Patients receiving statin therapy have been shown to experience less recurrent stenosis following carotid endarterectomy and stent angioplasty, reduced cardiac events following cardiac and noncardiac vascular surgery, and reduction in aneurysm development. In patients with peripheral arterial disease, claudication distance is increased, as well as patency rates following infrainguinal arterial bypass grafting. Of note, statins drugs may also prove beneficial in the prevention of certain cancers, Alzheimer's disease, and osteoporosis (all diseases frequently seen concurrently in the patient with peripheral arterial disease). As such, it is becoming all the more necessary that vascular surgeons remain informed about clinical research initiatives related to statin use and lipid management in general. The following is a review of lipid metabolism as it applies to statins as well as a review of the beneficial effects of statins.

Key Words: atherosclerosis • statin drug therapy • peripheral arterial disease

This version was published on August 1, 2008

Vascular and Endovascular Surgery, Vol. 42, No. 4, 352-366 (2008)
DOI: 10.1177/1538574408320524


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Mascitelli, F. Pezzetta, M. R. Goldstein, and R. H. Samson Questioning the Safety of Life-long Statin Therapy in Patients With Peripheral Arterial Disease Vascular and Endovascular Surgery, February 1, 2009; 43(1): 109 - 111. [PDF]

				K. I. Paraskevas, N. Bessias, J. Tzorbatzoglou, D. P. Mikhailidis, and V. Andrikopoulos Effect of Statins on Renal Function in Patients With Peripheral Arterial Disease Vascular and Endovascular Surgery, January 1, 2009; 42(6): 620 - 621. [PDF]